Crossmark

Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience

Crossref DOI link: https://doi.org/10.1038/s41409-022-01600-1

Published Online: 2022-02-05

Published Print: 2022-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Piemontese, Simona https://orcid.org/0000-0002-5908-0792
Lazzari, Lorenzo

Ruggeri, Annalisa

Marcatti, Magda

Lupo Stanghellini, Maria Teresa https://orcid.org/0000-0003-1382-6939
Giglio, Fabio

Greco, Raffaella https://orcid.org/0000-0002-6117-5328
Lorentino, Francesca

Clerici, Daniela

Assanelli, Andrea

Farina, Francesca

Mastaglio, Sara https://orcid.org/0000-0002-1638-3136
Xue, Elisabetta

Marktel, Sarah

Vago, Luca https://orcid.org/0000-0003-4247-3175
Gentner, Bernhard

Secco, Chiara

Corti, Consuelo

Carrabba, Matteo Giovanni

Bernardi, Massimo https://orcid.org/0000-0002-1334-0851
Peccatori, Jacopo

Ciceri, Fabio https://orcid.org/0000-0003-0873-0123
License Information

Text and Data Mining valid from 2022-02-05

Version of Record valid from 2022-02-05
More Information

Article History

Received: 6 December 2021

Revised: 21 January 2022

Accepted: 25 January 2022

First Online: 5 February 2022

Competing interests

: The authors declare no competing interests.

: A written informed consent was provided by all patients, allowing the use of medical records for research in accordance with the Declaration of Helsinki.

Document is current

Any future updates will be listed below